Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Automated Microbial Diagnostics

Automated Microbial Diagnostics

Automated diagnostic analyzers have transformed clinical microbiology by providing rapid and reliable methods for pathogen identification and antibiotic susceptibility testing. Among these systems, the Vitek 2 is widely used because it automates the traditionally labor-intensive processes of microbial identification (ID) and antibiotic susceptibility testing (AST), delivering standardized and timely results that are essential for effective patient care.Microbial Identification with ID CardsThe...

Issues And Trends In Healthcare Delivery System

Issues And Trends In Healthcare Delivery System

The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...

Pharmacogenomics: Identification of New Drug Targets

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Corrigendum to STAT1 promotes megakaryopoiesis downstream of GATA-1 in mice.

The Journal of clinical investigation·2025

Same author

CBL linker region and RING finger mutations lead to enhanced granulocyte-macrophage colony-stimulating factor (GM-CSF) signaling via elevated levels of JAK2 and LYN.

The Journal of biological chemistry·2013

Same author

Loss of JAK2 regulation via a heterodimeric VHL-SOCS1 E3 ubiquitin ligase underlies Chuvash polycythemia.

Nature medicine·2011

Same author

STAT1 promotes megakaryopoiesis downstream of GATA-1 in mice.

The Journal of clinical investigation·2007

Same author

Turning cells red: signal transduction mediated by erythropoietin.

Trends in cell biology·2005

Search research articles

Related Experiment Video

Updated: Jul 3, 2026

Standardized SDS-PAGE Workflow for Personalized Protein Corona Profiling in Early Cancer Detection

Standardized SDS-PAGE Workflow for Personalized Protein Corona Profiling in Early Cancer Detection

Published on: December 19, 2025

The current status and future potential of personalized diagnostics: Streamlining a customized process.

Terri D Richmond¹

¹School of Pharmacy, Regulatory Science Program, University of Southern California, Los Angeles, CA 90033, USA. terriric@usc.edu

Biotechnology Annual Review

|July 9, 2008

Summary

Personalized medicine leverages genetic insights for tailored disease detection and treatment. This approach requires collaboration between industry, academia, and regulatory bodies to navigate complex regulations for future advancements.

More Related Videos

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

Microfluidic Applications for Disposable Diagnostics

Microfluidic Applications for Disposable Diagnostics

Published on: February 3, 2008

Related Experiment Videos

Last Updated: Jul 3, 2026

Standardized SDS-PAGE Workflow for Personalized Protein Corona Profiling in Early Cancer Detection

Standardized SDS-PAGE Workflow for Personalized Protein Corona Profiling in Early Cancer Detection

Published on: December 19, 2025

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

Microfluidic Applications for Disposable Diagnostics

Microfluidic Applications for Disposable Diagnostics

Published on: February 3, 2008

Area of Science:

Genomics
Biotechnology
Medical Diagnostics

Background:

Genetic discoveries and genomic techniques enable novel diagnostic platforms.
Personalized medicine tailors disease detection, treatment, and prevention strategies using individual genetic composition.
Diagnostic tests identify gene or protein expression variations for drug treatment and disease prognosis.

Purpose of the Study:

To address the complex regulatory landscape of personalized medicine and diagnostics.
To discuss collaborations, advances, and regulatory guidances in the field.
To explore the future of personalized medicine and its associated challenges.

Main Methods:

Review of current regulatory frameworks and guidances.
Analysis of industry and FDA identified regulatory issues.
Discussion of collaborations between drug developers and regulatory authorities.

Main Results:

Personalized medicine offers patient-specific disease management strategies.
Regulatory complexities arise from integrating diagnostics, treatment, and patient care.
Collaboration is essential for developing and shaping regulations.

Conclusions:

Navigating the regulatory environment is crucial for the advancement of personalized medicine.
Ongoing collaboration and updated guidances are necessary to support personalized diagnostic and therapeutic strategies.
The future of personalized medicine depends on addressing current regulatory challenges.